Merck (MRK) Net Margin (2009 - 2026)

Merck has disclosed Net Margin across 17 years of filings, most recently posting 25.84% for Q1 2026.

• In Q1 2026, Net Margin fell 5859.0% year-over-year to 25.84%; the TTM figure through Mar 2026 stood at 13.64% (down 1366.0% YoY), while the FY2025 annual figure was 28.09%, up 139.0% from the prior year.
• Net Margin retreated to 25.84% in Q1 2026, from 18.06% in the prior quarter.
• Over the last five years, Net Margin for MRK reached as high as 33.89% in Q2 2024 and fell as low as 39.49% in Q2 2023.
• The 4-year median for Net Margin is 23.96% (2024), against an average of 14.99%.
• Annual changes were most pronounced in 2024 — Net Margin surged 7338 bps — and 2026, when it sank 5859 bps.
• A 4-year view of Net Margin shows it stood at 8.38% in 2023, then jumped by 386 bps to 23.96% in 2024, then decreased by 25 bps to 18.06% in 2025, then sank by 243 bps to 25.84% in 2026.
• According to Business Quant data, Net Margin over the past three periods registered 25.84%, 18.06%, and 33.5% for Q1 2026, Q4 2025, and Q3 2025 respectively.